A PROSPECTIVE STUDY OF TAPERING CONVENTIONAL DISEASE MODIFYING ANTIRHEUMATIC DRUGS (C-DMARDS) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN STABLE REMISSION

被引：0
|
作者：
Romi, Shah [1 ]
Balakrishnan, Canchi [1 ]
机构：
[1] PD Hinduja Hosp & Med Res Ctr, Mumbai, Maharashtra, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2592
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0189
引用
收藏
页码：370 / 371
页数：2
相关论文
共 50 条
  • [1] Utilization of disease modifying antirheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA).
    MacLean, CH
    Park, GS
    Traina, SB
    Liu, HH
    Hahn, BH
    Paulus, HE
    Kahn, KI
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S143 - S143
  • [2] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
    Ahmadreza Khoshroo
    Keyvan Ramezani
    Niusha Moghimi
    Moein Bonakdar
    Nazanin Ramezani
    [J]. Inflammopharmacology, 2023, 31 : 689 - 697
  • [3] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
    Khoshroo, Ahmadreza
    Ramezani, Keyvan
    Moghimi, Niusha
    Bonakdar, Moein
    Ramezani, Nazanin
    [J]. INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 689 - 697
  • [4] PARTICULARITIES OF TREATMENT WITH CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) IN A GROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Schiotis, Ruxandra Elena
    Gosa, Dana
    Bocsan, Corina
    Suciu, Soimita
    Buzoianu, Anca Dana
    [J]. FARMACIA, 2017, 65 (03) : 479 - 484
  • [5] POSTOPERATIVE COMPLICATIONS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING RITUXIMAB AND CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
    Pogozheva, E.
    Amirdzhanova, V.
    Makarov, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 882 - 882
  • [6] Incidence and severity of laboratory abnormalities during treatment with disease modifying antirheumatic drugs (DMARDS) in patients with rheumatoid arthritis (RA).
    Simon, CH
    Dijkmans, BAC
    Moens, HJB
    Vandenbroucke, JP
    Breedveld, FC
    Vlieland, TPMV
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S211 - S211
  • [7] EFFICIENCY OF NON-BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH COMORBIDITY
    Mykytenko, G.
    Iaremenko, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 212 - 213
  • [8] Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate
    Koyama, Yoshinobu
    Shiraishi, Hirokazu
    Ohta, Toshiyuki
    Uchino, Ayumi
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (01) : 100 - 108
  • [9] Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis
    Grijalva, Carlos G.
    Chung, Cecilia P.
    Arbogast, Patrick G.
    Stein, Charles M.
    Mitchel, Edward F., Jr.
    Griffin, Marie R.
    [J]. MEDICAL CARE, 2007, 45 (10) : S66 - S76
  • [10] DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE: A PROSPECTIVE STUDY
    Mena-Vazquez, N.
    Gomez-Cano, C.
    Aguilar-Hurtado, C.
    Rojas-Gimenez, M.
    Manrique-Arija, S.
    Domic, C.
    Fuego-Valera, C.
    Urena-Garnica, I.
    Jimenez-Nunez, F. G.
    Diaz-Cordoves, G.
    Irigoyen-Oyarzabal, M. V.
    Padin-Martin, M.
    Fernandez-Nebro, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 261 - 261
12345